UCH-L1 Antibodies

Santa Cruz Biotechnology features a diverse variety of UCH-L1 monoclonal antibodies for investigating UCH-L1 in cellular processes. UCH-L1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UCH-L1, or Ubiquitin C-terminal hydrolase L1, is a deubiquitinating enzyme essential for protein degradation and cellular homeostasis. UCH-L1 regulates protein turnover and has significant implications in neurodegenerative diseases, making it a crucial focus in neurobiology and cancer research. Research into UCH-L1 function continues to reveal new insights about disease progression mechanisms. Understanding UCH-L1's role may lead to breakthrough therapeutic strategies. Investigating UCH-L1 helps advance our knowledge of cellular protein regulation and degradation pathways. Santa Cruz Biotechnology monoclonal antibodies for UCH-L1 enable researchers worldwide to make meaningful contributions to neuroscience and cancer biology.